1. Association of Visfatin gene polymorphism with obesity related metabolic disorders among Pakistani population: a case control study.
- Author
-
Masood SH, Khan TA, Baloch AA, Hasan SM, Naqvi AM, and Iqbal MUN
- Subjects
- Humans, Case-Control Studies, Cytokines metabolism, Nicotinamide Phosphoribosyltransferase metabolism, Obesity metabolism, Pakistan epidemiology, Polymorphism, Single Nucleotide, Metabolic Syndrome genetics, Metabolic Syndrome complications
- Abstract
In recent years, the global prevalence of obesity and its associated metabolic disorders has reached alarming levels, presenting a significant challenge to public health worldwide. Visfatin, also known as pre-B cell colony-enhancing factor (PBEF) or nicotinamide phosphoribosyltransferase (NAMPT), is an adipokine that has been implicated in various physiological processes, including glucose homeostasis, lipid metabolism, and inflammation. The main objective of this proposed study is to find out the association between visfatin genetic variants and metabolic syndrome. The sample size of the study consisted of 300 blood samples (150 control and 150 cases). This study found that the genotypic frequency of visfatin SNPs, including rs2302559 (OD: 18.222; 95% CI 10.228-32.466; p-value < 0.001) and rs1215113036 (OD: 129.40; 95% CI 44.576-375.693; p-value < 0.001) were significantly associated with metabolic syndrome. Moreover, the frequency of the mutant alleles of both visfatin SNPs was found to be higher in patients with metabolic syndrome as compared to controls. Results of the current study indicate that people with any genetic variation of Visfatin, such as rs2302559 and rs1215113036, are more likely to develop metabolic syndrome. Visfatin genetic variants are linked to an increased risk of metabolic syndrome, implying it's role in disease pathophysiology., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF